Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 26, 2023; 11(6): 1287-1298
Published online Feb 26, 2023. doi: 10.12998/wjcc.v11.i6.1287
Published online Feb 26, 2023. doi: 10.12998/wjcc.v11.i6.1287
Patient characteristic | Normoglycemia | Hyperglycemia | Total | P value2 |
Male sex | 102 | 33 | 135 | 0.83 |
54.8% | 53.2% | 54.4% | ||
Vaccinated for COVID | 34 | 10 | 44 | 0.87 |
18.3% | 16.1% | 17.7% | ||
Hypertension | 81 | 36 | 117 | 0.0471 |
43.5% | 58.1% | 47.2% | ||
Family history of diabetes | 16 | 8 | 24 | 0.32 |
8.6% | 12.9% | 9.7% | ||
Prediabetes | 5 | 1 | 6 | 13 |
2.7% | 1.6% | 2.4% | ||
ADA - At risk | 96 | 41 | 137 | 0.05* |
51.6% | 66.1% | 55.2% | ||
Chronic liver disease | 7 | 2 | 9 | 1.00 |
3.8% | 3.2% | 3.6% | ||
Chronic obstructive pulmonary disease | 27 | 7 | 34 | 0.39 |
14.5% | 11.3% | 13.7% | ||
Congestive heart failure | 33 | 7 | 40 | 0.23 |
17.7% | 11.3% | 16.1% | ||
Chronic kidney disease | 31 | 11 | 42 | 0.85 |
16.7% | 17.7% | 16.9% |
- Citation: Geetha HS, Singh G, Sekar A, Gogtay M, Singh Y, Abraham GM, Trivedi N. Hyperglycemia in COVID-19 infection without diabetes mellitus: Association with inflammatory markers. World J Clin Cases 2023; 11(6): 1287-1298
- URL: https://www.wjgnet.com/2307-8960/full/v11/i6/1287.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i6.1287